BENVENUTI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.209
AS - Asia 1.429
EU - Europa 1.317
SA - Sud America 196
AF - Africa 86
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.244
Nazione #
US - Stati Uniti d'America 2.126
IT - Italia 656
SG - Singapore 493
CN - Cina 377
HK - Hong Kong 187
BR - Brasile 164
DE - Germania 111
VN - Vietnam 110
SE - Svezia 98
FI - Finlandia 76
FR - Francia 61
GB - Regno Unito 61
AT - Austria 56
JP - Giappone 47
BG - Bulgaria 46
IN - India 40
CA - Canada 39
NL - Olanda 38
KR - Corea 37
RU - Federazione Russa 30
MX - Messico 28
CI - Costa d'Avorio 25
IR - Iran 22
AR - Argentina 21
PL - Polonia 21
SN - Senegal 19
TR - Turchia 19
IQ - Iraq 14
CH - Svizzera 12
PK - Pakistan 12
BD - Bangladesh 11
UZ - Uzbekistan 11
ZA - Sudafrica 11
UA - Ucraina 8
CZ - Repubblica Ceca 7
ES - Italia 7
MA - Marocco 7
NG - Nigeria 7
PH - Filippine 7
ID - Indonesia 6
LT - Lituania 6
MY - Malesia 6
SA - Arabia Saudita 6
AU - Australia 5
IE - Irlanda 5
JM - Giamaica 5
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
EG - Egitto 3
GH - Ghana 3
JO - Giordania 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
UG - Uganda 2
AL - Albania 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.244
Città #
Ashburn 295
Singapore 263
Dallas 248
San Jose 229
Hong Kong 178
Santa Clara 134
Chandler 105
Fairfield 101
Milan 94
Pisa 77
Shanghai 72
Council Bluffs 64
Los Angeles 61
Boardman 58
Hefei 56
New York 56
Houston 52
Beijing 50
Wilmington 50
Seattle 49
Munich 46
Sofia 44
Florence 42
Vienna 42
Woodbridge 41
Rome 39
London 38
Cambridge 36
Seoul 36
Tokyo 36
Lucca 35
Serra 35
Lappeenranta 33
Ho Chi Minh City 26
Abidjan 25
Frankfurt am Main 24
Turku 22
Princeton 21
Chicago 20
Hanoi 20
Helsinki 20
Lauterbourg 20
Bremen 19
Dakar 19
Lawrence 16
Livorno 16
São Paulo 16
Medford 15
Naples 14
Warsaw 14
Atlanta 13
Buffalo 13
Dong Ket 13
Montignoso 13
Chennai 12
Montreal 12
Istanbul 11
Zurich 11
Ottawa 10
Redondo Beach 10
Tashkent 10
Columbus 9
Des Moines 9
Marseille 9
Nuremberg 9
Ogden 9
Toronto 9
Aguascalientes 8
Kent 8
Phoenix 8
San Giuliano Terme 8
Amsterdam 7
Ann Arbor 7
Brno 7
Johannesburg 7
Orem 7
Baltimore 6
Brooklyn 6
Lagos 6
Ottaviano 6
Pistoia 6
Wuhan 6
Xi'an 6
Baghdad 5
Cascina 5
Chengdu 5
Chieti 5
Da Nang 5
Dublin 5
Fuzhou 5
Kuala Lumpur 5
Mexico City 5
Modena 5
Moscow 5
Nanjing 5
Rio de Janeiro 5
Shenzhen 5
Belo Horizonte 4
Brescia 4
Campinas 4
Totale 3.495
Nome #
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 294
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 231
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 230
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 226
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 216
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 205
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 199
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 197
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 195
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 190
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 187
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 182
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 179
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 177
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 177
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 176
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 172
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 163
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy 149
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 145
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 143
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 137
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 136
Multivalent MMP-12 inhibitors as a valuable approach to counteract the intestinal epithelial barrier impairment and inflammation in an in vitro model mimicking intestinal high-fat exposure 123
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x) 122
Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy 117
Enteric glia at the crossroads between intestinal immune system and epithelial barrier: Implications for parkinson disease 117
Gut-directed therapy in Parkinson’s disease 116
Prolonged treatment with probiotics mitigates intestinal dysfunction and enteric Alzheimer's-related pathology in senescence-accelerated mice 111
null 103
The adenosine system at the crossroads of intestinal inflammation and neoplasia 99
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 97
A High-Molecular-Weight Fraction of Planarian Mucus Triggers UPR-Linked Cell Death Pathway in Human Bronchioalveolar Carcinoma Cell Line NCI-H358 31
Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging 23
Simulated Mars Gravity Impairs Intestinal Epithelial Barrier Integrity via Selective Modulation of Tight Junction Components 20
Enteric Glial Cell Culture to Mimic In Vivo Obesity and Neurodegenerative Disorders 5
Totale 5.390
Categoria #
all - tutte 16.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 11 2 5 7 41 31 8 6 20 16 19 46
2022/2023514 39 66 38 34 63 55 4 47 106 19 34 9
2023/2024569 33 49 76 34 70 67 17 42 36 38 43 64
2024/20251.336 28 38 34 81 89 167 138 67 148 128 172 246
2025/20262.202 129 216 272 209 217 142 272 117 159 233 99 137
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 5.390